AAAAAA

   
Results: 1-10 |
Results: 10
DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY
Authors: LAHTI RA ROBERTS RC COCHRANE EV PRIMUS RJ GALLAGER DW CONLEY RR TAMMINGA CA
Citation: Ra. Lahti et al., DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY, Molecular psychiatry, 3(6), 1998, pp. 528-533
DOPAMINE D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN-TISSUE OF NORMAL ANDSCHIZOPHRENIC SUBJECTS, AN [(3)]NGD-94-1 STUDY
Authors: LAHTI RA ROBERTS RC COCHRANE EV PRIMUS RJ GALLAGER DW TAMMINGA CA
Citation: Ra. Lahti et al., DOPAMINE D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN-TISSUE OF NORMAL ANDSCHIZOPHRENIC SUBJECTS, AN [(3)]NGD-94-1 STUDY, Schizophrenia research, 29(1-2), 1998, pp. 93-93
IN-VITRO AUTORADIOGRAPHY OF GTP-GAMMA[S-35] BINDING AT ACTIVATED NPY RECEPTOR SUBTYPES IN ADULT-RAT BRAIN
Authors: PRIMUS RJ YEVICH E GALLAGER DW
Citation: Rj. Primus et al., IN-VITRO AUTORADIOGRAPHY OF GTP-GAMMA[S-35] BINDING AT ACTIVATED NPY RECEPTOR SUBTYPES IN ADULT-RAT BRAIN, Molecular brain research, 58(1-2), 1998, pp. 74-82
[H-3] NGD-94-1 BINDING IN HUMAN POSTMORTEM BRAIN OF NORMALS AND SCHIZOPHRENICS OFF-ANTIPSYCHOTIC, OR ON-ANTIPSYCHOTIC DRUGS AT DEATH
Authors: LAHTI RA ROBERTS RC COCHRANE EV PRIMUS RJ GALLAGER DW TAMMINGA CA
Citation: Ra. Lahti et al., [H-3] NGD-94-1 BINDING IN HUMAN POSTMORTEM BRAIN OF NORMALS AND SCHIZOPHRENICS OFF-ANTIPSYCHOTIC, OR ON-ANTIPSYCHOTIC DRUGS AT DEATH, Schizophrenia research, 24(1-2), 1997, pp. 35-35
AUTORADIOGRAPHIC LOCALIZATION OF CRF1 AND CRF2 BINDING-SITES IN ADULT-RAT BRAIN
Authors: PRIMUS RJ YEVICH E BALTAZAR C GALLAGER DW
Citation: Rj. Primus et al., AUTORADIOGRAPHIC LOCALIZATION OF CRF1 AND CRF2 BINDING-SITES IN ADULT-RAT BRAIN, Neuropsychopharmacology, 17(5), 1997, pp. 308-316
NGD-94-1 - IDENTIFICATION OF A NOVEL, HIGH-AFFINITY ANTAGONIST AT THEHUMAN DOPAMINE-D-4 RECEPTOR .1.
Authors: TALLMAN JF PRIMUS RJ BRODBECK R CORNFIELD L MEADE R WOODRUFF K ROSS P THURKAUF A GALLAGER DW
Citation: Jf. Tallman et al., NGD-94-1 - IDENTIFICATION OF A NOVEL, HIGH-AFFINITY ANTAGONIST AT THEHUMAN DOPAMINE-D-4 RECEPTOR .1., The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 1011-1019
LOCALIZATION AND CHARACTERIZATION OF DOPAMINE-D-4 BINDING-SITES IN RAT AND HUMAN BRAIN BY USE OF THE NOVEL, D-4-RECEPTOR-SELECTIVE LIGAND [H-3] NGD-94-1 .2.
Authors: PRIMUS RJ THURKAUF A XU J YEVICH E MCINERNEY S SHAW K TALLMAN JF GALLAGER DW
Citation: Rj. Primus et al., LOCALIZATION AND CHARACTERIZATION OF DOPAMINE-D-4 BINDING-SITES IN RAT AND HUMAN BRAIN BY USE OF THE NOVEL, D-4-RECEPTOR-SELECTIVE LIGAND [H-3] NGD-94-1 .2., The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 1020-1027
EFFECT OF SUBUNIT COMPOSITION ON GABA(A)-RECEPTOR COMPLEX CHARACTERISTICS IN A BACULOVIRUS EXPRESSION SYSTEM
Authors: HARTNETT C BROWN MS YU J PRIMUS RJ MEYYAPPAN M WHITE G STIRLING VB TALLMAN JF RAMABHADRAN TV GALLAGER DW
Citation: C. Hartnett et al., EFFECT OF SUBUNIT COMPOSITION ON GABA(A)-RECEPTOR COMPLEX CHARACTERISTICS IN A BACULOVIRUS EXPRESSION SYSTEM, Receptors & channels, 4(3), 1996, pp. 179-195
DISTRIBUTION OF DOPAMINE D-4 RECEPTOR IN HUMAN POSTMORTEM BRAIN SECTIONS - AUTORADIOGRAPHIC STUDIES WITH [H-3] NGD-94-1
Authors: LAHTI RA PRIMUS RJ GALLAGER DW ROBERTS R TAMMINGA CA
Citation: Ra. Lahti et al., DISTRIBUTION OF DOPAMINE D-4 RECEPTOR IN HUMAN POSTMORTEM BRAIN SECTIONS - AUTORADIOGRAPHIC STUDIES WITH [H-3] NGD-94-1, Schizophrenia research, 18(2-3), 1996, pp. 2-2
ALLOSTERIC UNCOUPLING AFTER CHRONIC BENZODIAZEPINE EXPOSURE OF RECOMBINANT GAMMA-AMINOBUTYRIC ACID(A) RECEPTORS EXPRESSED IN SF9 CELLS - LIGAND EFFICACY AND SUBTYPE SELECTIVITY
Authors: PRIMUS RJ YU J XU J HARTNETT C MEYYAPPAN M KOSTAS C RAMABHADRAN TV GALLAGER DW
Citation: Rj. Primus et al., ALLOSTERIC UNCOUPLING AFTER CHRONIC BENZODIAZEPINE EXPOSURE OF RECOMBINANT GAMMA-AMINOBUTYRIC ACID(A) RECEPTORS EXPRESSED IN SF9 CELLS - LIGAND EFFICACY AND SUBTYPE SELECTIVITY, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 882-890
Risultati: 1-10 |